MedTech News
Catheter Precision’s (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
FORT MILL, SC / ACCESSWIRE / November 20, 2023 / Catheter Precision, Inc. (the “Company”) (NYSE American:VTAK), a pioneering medical technology firm headquartered in the United States, specializing in electrophysiology devices, has proudly disclosed the successful conclusion of the inaugural VIVO cases in the region of South-Eastern Europe. VIVO, the Company’s innovative 3D non-invasive imaging system, is used pre-procedurally to identify areas of interest for ventricular ablation and aid in pre-procedure planning to reduce procedure time and aid in procedural accuracy.
Medtronic pulsed-field ablation system wins CE mark
Medtronic (NYSE: MDT)+
said today that it’s received a CE mark for its PulseSelect pulsed field ablation system.
Ingestible electronic device detects breathing depression in patients
The new sensor measures heart and breathing rate from patients with sleep apnea and could also be used to monitor people at risk of opioid overdose.
A new ultrasound patch can measure how full your bladder is
The wearable device, designed to monitor bladder and kidney health, could be adapted for earlier diagnosis of cancers deep within the body.
First-of-their-kind wearables capture body sounds to continuously monitor health
New devices were tested on a range of patients, from premature babies to the elderly
LetsGetChecked secures first FDA authorization for at-home chlamydia and gonorrhea test
Jeff Shuren, director of the Center for Devices and Radiological Health, said the test will give patients “more information about their health from the privacy of
their own home.”
Abbott study links aspirin-free regimen to better outcomes in heart pump patients
An accompanying editorial said the “data provide an opportunity to immediately improve the outcomes of patients implanted with contemporary LVADs.”
MONARCH Platform for Bronchoscopy Receives Regulatory License for China
The MONARCH™ Platform is the first minimally invasive, robotic-assisted technology approved for bronchoscopy in a country with significant burden of lung cancer.